Sapiens International Corporation NV
NASDAQ:SPNS
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
26.57
41.02
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Sapiens International Corporation NV
Sapiens International Corporation NV
Total Receivables
Sapiens International Corporation NV
Total Receivables Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Sapiens International Corporation NV
NASDAQ:SPNS
|
Total Receivables
$135.4m
|
CAGR 3-Years
14%
|
CAGR 5-Years
16%
|
CAGR 10-Years
16%
|
|
|
Walkme Ltd
NASDAQ:WKME
|
Total Receivables
$40.5m
|
CAGR 3-Years
9%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
N
|
Nice Ltd
TASE:NICE
|
Total Receivables
$629.9m
|
CAGR 3-Years
21%
|
CAGR 5-Years
19%
|
CAGR 10-Years
12%
|
|
|
Cellebrite DI Ltd
NASDAQ:CLBT
|
Total Receivables
$83.4m
|
CAGR 3-Years
6%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
H
|
Hilan Ltd
TASE:HLAN
|
Total Receivables
₪951m
|
CAGR 3-Years
17%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
23%
|
|
|
Similarweb Ltd
NYSE:SMWB
|
Total Receivables
$49.3m
|
CAGR 3-Years
24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
Sapiens International Corporation NV
Glance View
Sapiens International Corporation NV stands as a notable player in the world of insurance software solutions, carving out a niche that seamlessly intertwines technology and business acumen. Originating from Israel, the company has expanded its reach across the globe, serving clients in more than 30 countries. At its core, Sapiens develops sophisticated software tailored for the insurance industry, addressing the unique needs of both property and casualty (P&C) and life insurance sectors. By providing a blend of digital insurance platforms and specialized consulting services, Sapiens empowers insurance firms to modernize core processes, enhance customer experiences, and adapt to volatile market dynamics. This alignment with industry needs places Sapiens in a strategic position, fostering deep, long-term partnerships with insurers eager to stay ahead in the digital transformation race. Financially, Sapiens operates on a robust business model predicated on a mix of software licensing, subscription fees, and consulting revenue streams. The company’s licensing model allows insurance companies to utilize their software, ensuring a steady inflow of revenue from initial and periodic renewal fees. Subscription models further bolster this income, categorizing Sapiens as a key player in the software-as-a-service (SaaS) domain—a growing trend in the tech world. Additionally, consulting and support services allow Sapiens to monetize their expertise, guiding clients through the nuances of system integration, compliance adaptations, and technological upgrades. This diversified revenue matrix not only provides stability but also underpins Sapiens' growth strategy, attesting to its adaptability in an ever-evolving industry landscape.
See Also
What is Sapiens International Corporation NV's Total Receivables?
Total Receivables
135.4m
USD
Based on the financial report for Sep 30, 2024, Sapiens International Corporation NV's Total Receivables amounts to 135.4m USD.
What is Sapiens International Corporation NV's Total Receivables growth rate?
Total Receivables CAGR 10Y
16%
Over the last year, the Total Receivables growth was 15%. The average annual Total Receivables growth rates for Sapiens International Corporation NV have been 14% over the past three years , 16% over the past five years , and 16% over the past ten years .
You don't have any saved screeners yet
